HomeCompareDGNYF vs CL

DGNYF vs CL: Dividend Comparison 2026

DGNYF yields 33.33% · CL yields 2.44%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DGNYF wins by $119.2K in total portfolio value
10 years
DGNYF
DGNYF
● Live price
33.33%
Share price
$6.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$160.1K
Annual income
$23,203.52
Full DGNYF calculator →
CL
CL
● Live price
2.44%
Share price
$85.23
Annual div
$2.08
5Y div CAGR
28.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$41.0K
Annual income
$5,451.69
Full CL calculator →

Portfolio growth — DGNYF vs CL

📍 DGNYF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodDGNYFCL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, DGNYF + CL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
DGNYF pays
CL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DGNYF
Annual income on $10K today (after 15% tax)
$2,833.33/yr
After 10yr DRIP, annual income (after tax)
$19,722.99/yr
CL
Annual income on $10K today (after 15% tax)
$207.44/yr
After 10yr DRIP, annual income (after tax)
$4,633.94/yr
At 15% tax rate, DGNYF beats the other by $15,089.06/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DGNYF + CL for your $10,000?

DGNYF: 50%CL: 50%
100% CL50/50100% DGNYF
Portfolio after 10yr
$100.6K
Annual income
$14,327.61/yr
Blended yield
14.25%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CL right now

DGNYF
No analyst data
CL
Analyst Ratings
17
Buy
24
Hold
2
Sell
Consensus: Hold
Price Target
$92.45
+8.5% upside vs current
Range: $85.00 — $100.00
Altman Z
4.5
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DGNYF buys
0
CL buys
0
No recent congressional trades found for DGNYF or CL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricDGNYFCL
Forward yield33.33%2.44%
Annual dividend / share$2.00$2.08
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28.6%
Portfolio after 10y$160.1K$41.0K
Annual income after 10y$23,203.52$5,451.69
Total dividends collected$113.6K$18.1K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: DGNYF vs CL ($10,000, DRIP)

YearDGNYF PortfolioDGNYF Income/yrCL PortfolioCL Income/yrGap
1← crossover$14,033$3,333.33$11,014$313.84+$3.0KDGNYF
2$19,387$4,371.75$12,200$415.44+$7.2KDGNYF
3$26,389$5,644.57$13,607$553.09+$12.8KDGNYF
4$35,417$7,180.46$15,301$741.41+$20.1KDGNYF
5$46,902$9,006.44$17,374$1,002.00+$29.5KDGNYF
6$61,333$11,146.93$19,958$1,367.44+$41.4KDGNYF
7$79,249$13,622.82$23,243$1,887.87+$56.0KDGNYF
8$101,247$16,450.69$27,512$2,642.43+$73.7KDGNYF
9$127,976$19,642.17$33,197$3,759.22+$94.8KDGNYF
10$160,138$23,203.52$40,973$5,451.69+$119.2KDGNYF

DGNYF vs CL: Complete Analysis 2026

DGNYFStock

Dignity plc, together with its subsidiaries, provides funeral services in the United Kingdom. It operates through three segments: Funeral Services, Crematoria, and Pre–arranged Funeral Plans. The Funeral Services segment provides funerals and ancillary items, such as memorials and floral tributes. The Crematoria segment offers cremation services, as well as sells memorials and burial plots at the company operated crematoria and cemeteries. The Pre–arranged Funeral Plans segment sells funerals in advance to customers wishing to make their own funeral arrangements. As of December 31, 2021, it owned 776 funeral locations in the United Kingdom. The company was founded in 1812 and is headquartered in Sutton Coldfield, the United Kingdom.

Full DGNYF Calculator →

CLConsumer Staples

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

Full CL Calculator →
📬

Get this DGNYF vs CL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DGNYF vs SCHDDGNYF vs JEPIDGNYF vs ODGNYF vs KODGNYF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.